Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia (2015)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacl.2014.12.008
- Subjects: HIPERCOLESTEROLEMIA; LIPOPROTEÍNAS; OLIGOPEPTÍDEOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of clinical lipidology
- ISSN: 1933-2874
- Volume/Número/Paginação/Ano: v. 9, n. 2, p. 201-209, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
SANTOS, Raul D. et al. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. Journal of clinical lipidology, v. 9, n. 2, p. 201-209, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2014.12.008. Acesso em: 12 jan. 2026. -
APA
Santos, R. D., Raal, F. J., Donovan, J. M., & Crowell, W. C. (2015). Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. Journal of clinical lipidology, 9( 2), 201-209. doi:10.1016/j.jacl.2014.12.008 -
NLM
Santos RD, Raal FJ, Donovan JM, Crowell WC. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia [Internet]. Journal of clinical lipidology. 2015 ; 9( 2): 201-209.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1016/j.jacl.2014.12.008 -
Vancouver
Santos RD, Raal FJ, Donovan JM, Crowell WC. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia [Internet]. Journal of clinical lipidology. 2015 ; 9( 2): 201-209.[citado 2026 jan. 12 ] Available from: https://doi.org/10.1016/j.jacl.2014.12.008 - Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia
- Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)
- Check-up e progressão do risco cardiovascular: existe espaço para inovação?
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia Executive summary
- Relation of Physical Activity to Prevalence of Nonalcoholic Fatty Liver Disease Independent of Cardiometabolic Risk
- Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management
- Tratamento das dislipidemias
- Recommendations for the management of patients with familial hypercholesterolemia
- Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglycerid levels in the Arabian Gulf
- Testosterone: A vascular hormone? Commentary on the study of Vlachopoulos et al.
Informações sobre o DOI: 10.1016/j.jacl.2014.12.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
